StonvexLoading…
StonvexStonvexStonvexCore line items from SLGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.48B | $5.85B | $5.99B | $6.41B |
Operating Income | $408.50M | $347.67M | $422.12M | $474.14M |
Net Income | $288.40M | $276.38M | $325.96M | $340.85M |
EPS (Diluted) | $2.70 | $2.58 | $2.98 | $3.07 |
Total Assets | $9.40B | $8.58B | $7.61B | $7.35B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.08B | $822.85M | $642.92M | $585.62M |
Free Cash Flow OCF − CapEx | $422.75M | $459.09M | $255.79M | $532.65M |
Shares Outstanding | 105.44M | 106.79M | 106.50M | 110.08M |